Northwestern sues Moderna for patent infringement over 19 vaccines

Reuters

Northwestern sues Moderna for patent infringement over 19 vaccines

10:34 chiều giờ GMT, 16 Tháng 10 2024

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Northwestern sues Moderna for patent infringement over COVID-19 vaccines</title></head><body>

By Blake Brittain

Oct 16 (Reuters) -Moderna MRNA.O was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax.

The lawsuit said Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport fragile messenger RNA into the human body.

A Moderna spokesperson said the company was aware of the lawsuit and will defend itself against the claims. Attorneys and spokespeople for Northwestern did not immediately respond to a request for comment.

The lawsuit adds to a web of U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their COVID vaccines, including one brought by Moderna against Pfizer in 2022. British pharmaceutical company GlaxoSmithKline sued Moderna in the same Delaware court on Tuesday for allegedly misusing GSK's LNP technology in its COVID-19 and RSV shots.

Evanston, Illinois-based Northwestern said its researchers pioneered the use of LNPs to deliver mRNA into human cells in 2009 and 2010. The university's lawsuit said the LNPs in Moderna's Spikevax work in the same way as its patented technology.

The school's complaint said Moderna could not have made its "rapid progress" in developing the vaccine "without appropriating the technological breakthroughs of prior researchers, including those at Northwestern."

Northwestern asked the court for an unspecified amount of monetary damages from Moderna's alleged infringement including royalties. Moderna earned $6.7 billion in revenue from Spikevax last year.

The case is Northwestern University v. Moderna Inc, U.S. District Court for the District of Delaware, No. 1:24-cv-01151.

For Northwestern: Rebecca Horwitz, John Hughes, Mac LeBuhn and Katherine Rhoades of Bartlit Beck

For Moderna: Not yet available

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

GSK sues Moderna for US patent infringement over COVID, RSV vaccines

Reporting by Blake Brittain in Washington

</body></html>